Delivery Order 75R60220D00001-75R60221F34105

The Office of the Assistant Secretary for Preparedness and Response (ASPR) awarded a $3.55M firm fixed-price definitive contract to Children's Research Institute on August 23, 2024, to establish and operate a Special Populations Hub under the Biomedical Advanced Research and Development Authority's (BARDA) Accelerator Network 2.0 initiative. This hub will provide wraparound accelerator services focused on pediatric medical countermeasures and innovation, leveraging Children's Research...

This is a definitive, firm-fixed price contract awarded by the Department of Health and Human Services Centers for Disease Control and Prevention to The Children's Hospital of Philadelphia (CHOP) on July 1, 2020. The contract, valued at $449,879.00, is for a project titled "PERINATAL COVID-19 IN THE UNITED STATES: SURVEILLANCE AND EPIDEMIOLOGY" with a completion date of September 30, 2022. The contract does not have a set-aside designation. CHOP, a non-profit pediatric hospital and...

The National Institute of Child Health and Human Development (NICHD) has awarded a $17,268,194 delivery order contract to Duke University for the Best Pharmaceuticals for Children Act (BPCA) Pediatric Trials Network (PTN) program. This contract is part of a larger BPCA PTN indefinite delivery vehicle (IDV), with a ceiling value of up to $149 million. Under this contract, Duke University will establish and maintain centralized teams of experts to develop protocols and informed consent forms,...

This is a $912,926 firm fixed-price contract awarded by the Department of Health and Human Services (HHS) Centers for Disease Control and Prevention (CDC) to the University of North Carolina at Chapel Hill's Office of Sponsored Research. The contract is for the establishment and coordination of a regional public health emergency preparedness and response (PHEPR) body that will determine focus areas, priorities, and develop a five-year workplan. This is part of a larger CDC initiative to award up...

This federal contract award is a delivery order under the Vaccine and Treatment Evaluation Units (VTEU) indefinite-delivery/indefinite-quantity (IDIQ) contract, which is administered by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH). The $579,562.32 award was made to Children's Hospital Medical Center, a non-profit pediatric hospital and research center in Cincinnati, Ohio, to conduct a clinical trial of an influenza...

The Office of the Assistant Secretary for Preparedness and Response (ASPR) awarded a $222.1 million definitive contract to PPD Development LP on December 15, 2023, to implement a randomized, double-blind, placebo-controlled, multicenter Phase 2 clinical trial evaluating the safety and efficacy of novel host-directed therapeutic candidates in hospitalized adults with acute respiratory distress syndrome (ARDS). The contract, structured as cost-plus-incentive pricing with no set-aside...

This is a firm fixed-price purchase order contract awarded by the Department of Health and Human Services Centers for Disease Control and Prevention to The Children's Hospital of Philadelphia (CHOP) for a rotavirus vaccine study in a neonatal intensive care unit (NICU). The potential value of the contract is $249,179.00, with a completion date of April 30, 2022. CHOP is a pediatric hospital and research center that has received numerous federal contracts and grants from agencies like the...

This is a federal contract award from the National Institute of Child Health and Human Development (NICHD), a part of the Department of Health and Human Services (HHS), to Duke University for clinical research related to pediatric trials. The contract, valued at $1,782,151.00, was awarded on September 20, 2015, with a period of performance through September 28, 2018. The contract is a delivery order and is not set-aside for any specific socioeconomic designation. As the prime contractor, Duke...

This federal contract award is for Protocol Development (base) and Protocol Implementation (options 1-6) services related to a Phase II clinical trial (Protocol 14-0112) to evaluate the safety, reactogenicity, and immunogenicity of the M-001 influenza A/H7N9 vaccine in healthy volunteers. The award was made by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the Department of Health and Human Services, under the Vaccine and Treatment Evaluation Units...

The Department of Health and Human Services Office of the Assistant Secretary for Preparedness and Response awarded a $14.8 million firm fixed price purchase order to Hologic, Inc. to deliver its respiratory panel test for SARS-CoV, influenza A, influenza B, and RSV. The test will be used on Hologic's Panther Fusion system. The contract supports the agency's coronavirus COVID-19 response efforts and requires performance in San Diego, California over a base period ending in September 2022. No set...